DE69003257T2 - Tetralin-Derivate. - Google Patents

Tetralin-Derivate.

Info

Publication number
DE69003257T2
DE69003257T2 DE90400031T DE69003257T DE69003257T2 DE 69003257 T2 DE69003257 T2 DE 69003257T2 DE 90400031 T DE90400031 T DE 90400031T DE 69003257 T DE69003257 T DE 69003257T DE 69003257 T2 DE69003257 T2 DE 69003257T2
Authority
DE
Germany
Prior art keywords
tetralin derivatives
tetralin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90400031T
Other languages
English (en)
Other versions
DE69003257D1 (de
Inventor
Orchymont Hugues D
Celine Tarnus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69003257D1 publication Critical patent/DE69003257D1/de
Publication of DE69003257T2 publication Critical patent/DE69003257T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/04—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
    • C07C225/08—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • C07C225/12—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings with doubly-bound oxygen atoms bound to carbon atoms being part of rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/01—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms
    • C07C205/03—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C205/04—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/28—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/31—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/32—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups bound to acyclic carbon atoms and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/41—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE90400031T 1989-01-09 1990-01-05 Tetralin-Derivate. Expired - Fee Related DE69003257T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89400056A EP0381902A1 (de) 1989-01-09 1989-01-09 Tetralin-Derivate

Publications (2)

Publication Number Publication Date
DE69003257D1 DE69003257D1 (de) 1993-10-21
DE69003257T2 true DE69003257T2 (de) 1994-01-13

Family

ID=8202914

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90400031T Expired - Fee Related DE69003257T2 (de) 1989-01-09 1990-01-05 Tetralin-Derivate.

Country Status (21)

Country Link
US (1) US5041673A (de)
EP (2) EP0381902A1 (de)
JP (1) JP2761955B2 (de)
KR (1) KR0177805B1 (de)
CN (1) CN1022319C (de)
AR (1) AR247722A1 (de)
AT (1) ATE94533T1 (de)
AU (1) AU620676B2 (de)
CA (1) CA2007261C (de)
DE (1) DE69003257T2 (de)
DK (1) DK0378456T3 (de)
ES (1) ES2060076T3 (de)
FI (1) FI100799B (de)
HU (1) HU212494B (de)
IE (1) IE62997B1 (de)
IL (1) IL92986A (de)
NO (1) NO171722C (de)
NZ (1) NZ232031A (de)
PH (1) PH27288A (de)
PT (1) PT92808B (de)
ZA (1) ZA9034B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
GB9509156D0 (en) 1995-05-05 1995-06-28 Sandoz Ltd Organic compounds
US6844368B1 (en) 1998-12-22 2005-01-18 Edward Roberts Compounds useful in pain management
WO2000037426A1 (en) * 1998-12-22 2000-06-29 Astrazeneca Ab Novel oxo-aminotetralin compounds useful in pain management
PL207809B1 (pl) 2003-11-20 2011-02-28 Invento Społka Z Ograniczoną Odpowiedzialnością Preforma pojemnika z tworzywa sztucznego, zwłaszcza do środków spożywczych
CN102631664B (zh) * 2011-01-28 2014-10-01 上海来益生物药物研究开发中心有限责任公司 3-氨基-2-羟基-4-苯基-缬氨酰-异亮氨酸的应用
WO2021039023A1 (ja) * 2019-08-23 2021-03-04 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の製造方法
CN112275147B (zh) * 2020-09-01 2021-08-13 中国科学院山西煤炭化学研究所 一种自聚微孔聚酰亚胺气体分离膜及其制备方法和应用
WO2023154896A2 (en) * 2022-02-11 2023-08-17 Adarx Pharmaceuticals, Inc. Trkb ligand conjugated compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267373A (en) * 1972-07-03 1981-05-12 E. R. Squibb & Sons, Inc. 5,6,7,8-Tetrahydronaphthalene hypotensive agents
JPS561305B2 (de) * 1972-12-18 1981-01-13
US3993677A (en) * 1975-11-03 1976-11-23 American Cyanamid Company 1,2,3,4-Tetrahydro-4-oxo-1-naphthylisocyanate
US4049717A (en) * 1976-05-13 1977-09-20 American Cyanamid Company Novel 1,2,3,4-tetrahydro-4-oxo-(oxy)-1-naphthylamines and method of preparation thereof
US4041070A (en) * 1976-07-14 1977-08-09 American Cyanamid Company Tetrahydro-4-imino-1-naphthylureas
US4051183A (en) * 1976-09-02 1977-09-27 American Cyanamid Company 1-benzoyl-3-(1,2,3,4-tetrahydro-4-oxo-1-naphthyl)-urea, a novel and useful intermediate for the preparation of animal growth promoting agents
JPS6045179B2 (ja) * 1977-06-08 1985-10-08 フナイ薬品工業株式会社 新規環状アミノアルコ−ル類およびその製造法

Also Published As

Publication number Publication date
PT92808A (pt) 1990-07-31
NO171722B (no) 1993-01-18
IE900067L (en) 1990-07-09
KR0177805B1 (ko) 1999-05-15
PT92808B (pt) 1995-12-29
CN1022319C (zh) 1993-10-06
JP2761955B2 (ja) 1998-06-04
DK0378456T3 (da) 1993-10-25
FI100799B (fi) 1998-02-27
NO171722C (no) 1993-04-28
ZA9034B (en) 1990-10-31
US5041673A (en) 1991-08-20
IL92986A (en) 1994-05-30
KR900011709A (ko) 1990-08-02
EP0381902A1 (de) 1990-08-16
HU212494B (en) 1996-07-29
EP0378456A1 (de) 1990-07-18
FI900083A0 (fi) 1990-01-08
CA2007261C (en) 2000-04-11
ES2060076T3 (es) 1994-11-16
AR247722A1 (es) 1995-03-31
CA2007261A1 (en) 1990-07-09
NO900074D0 (no) 1990-01-08
JPH02233650A (ja) 1990-09-17
IE62997B1 (en) 1995-03-08
NO900074L (no) 1990-07-10
PH27288A (en) 1993-05-04
CN1044460A (zh) 1990-08-08
AU620676B2 (en) 1992-02-20
AU4782790A (en) 1990-07-12
ATE94533T1 (de) 1993-10-15
HUT58271A (en) 1992-02-28
EP0378456B1 (de) 1993-09-15
NZ232031A (en) 1992-07-28
HU900068D0 (en) 1990-03-28
FI900083A (fi) 1990-07-10
IL92986A0 (en) 1990-09-17
DE69003257D1 (de) 1993-10-21

Similar Documents

Publication Publication Date Title
DE69017066D1 (de) 3-Substituierte-2-Oxindolderivate als Entzündungshemmender.
DE69006100T2 (de) Fibronektin-Derivate.
DE69008682D1 (de) Guanidinobenzolderivate.
FI890803A0 (fi) Inmatningssystem foer braennluft i en aotervinningspanna.
ATE124407T1 (de) Chromanderivate.
DE69022965T2 (de) Aminopiperazinderivate.
DE69017383D1 (de) Substituierte bicycloheptadionderivate.
ATE116985T1 (de) Chromanderivate.
DE69003257D1 (de) Tetralin-Derivate.
DE69017657T2 (de) Pyridinderivate.
FI890587A (fi) Reaktorkammare i en reaktor med fluidiserad baedd.
DE69005904T2 (de) Phenylpyrimidonderivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE69019217D1 (de) Perylenquinon (UCN-1028D)-Derivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
NO903229D0 (no) Substituerte isoksazol- og isotiazolderivater.
DE69015726D1 (de) Piperidylthiocarbapenem-Derivate.
DE69004991T2 (de) Diphenyldiacetylenderivate.
DE69001450D1 (de) Dihydroxynaphthalin-derivate.
FI900932A (fi) Minnesdosa foer anvaendning i samband med tv-spelmaskin.
DE69009145D1 (de) Anthantron-Derivate.
ATE88694T1 (de) Dihydroxynaphthalin-derivate.
ATE94875T1 (de) Chinazolinderivate.
MX9203570A (es) Derivados de carboestirilo.
DE59007923D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee